Integra LifeSciences Holdings Corporation (IART)
$13.44+0.22%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.0B
- Beta
- 1.21
- P/E (TTM)
- -144.47
- Short % float
- 12.38%
- Days to cover
- 7.5
- SI change
- +6.8%
- 1W
- +5.99%
- 1M
- -13.51%
- vs SPY 1W
- +4.83%
- vs SPY 1M
- -16.51%
Industry peers
FMP comparable companies · ranked by market cap
- SYKSELLStryker Corporation$106.2BRECOVERYQ 25$276.97+0.13%
- SNNSELLSmith & Nephew plc$11.3BRECOVERYQ 15$26.96+1.04%
- GMEDSELLGlobus Medical, Inc.$9.9BRECOVERYQ 22$73.33+1.80%
- AXGNSELLAxoGen, Inc.$1.9BCRISISQ 16$36.18-0.14%
- ATECBUYAlphatec Holdings, Inc.$1.6BRECOVERYQ -0$10.35+3.09%
- CNMDSELLCONMED Corporation$1.4BRECOVERYQ 13$45.11-1.53%
- AORTSELLArtivion, Inc.$1.0BCRISISQ 3$21.21+0.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IART?
- LOPJLB’s latest quantitative signal on Integra LifeSciences Holdings Corporation (IART) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IART in?
- Integra LifeSciences Holdings Corporation (IART) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Integra LifeSciences Holdings Corporation (IART) do?
- Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty S…